| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/02/2007 | US7276344 Osteoclastogenesis inhibitory factor protein for treating osteoporosis |
| 10/02/2007 | US7276342 Reduce body mass; obesity therapy; hyperlipemia; insulin resistance; atherosclerosis; antidiabetic agents; hypotensive agents |
| 10/02/2007 | US7276341 Methods and reagents for diagnosis of autoantibodies |
| 10/02/2007 | US7276339 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 10/02/2007 | US7276333 Viral infection inhibitor targeting integrase N-terminal domain |
| 10/02/2007 | US7276331 Plus end-directed microtubule motor required for chromosome congression |
| 10/02/2007 | US7276243 Nucleic acid having a sequence that is codon-optimized for high level expression in a yeast cell; proteins produced provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity |
| 10/02/2007 | US7276242 Fowl pox viral construct composed of a first nucleic acid molecule encoding HIV Gag and/or Pol or derivatives and a second nucleic acid molecule encoding gamma-interferon and derivatives, effective in inducing, enhancing or otherwise stimulating an immune response to Gag and/or Pol. |
| 10/02/2007 | US7276241 Anticancer agents; administering polypeptide antagonist |
| 10/02/2007 | US7276240 Antibodies to novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 10/02/2007 | US7276239 Recombinant A2-specific TNFα-specific antibodies |
| 10/02/2007 | US7276238 Using thymus expressed chemokine (TECK) receptor as tool in detection of modulators for prevention and treatment of inflammatory, gastrointestinal and viral diseases |
| 10/02/2007 | US7276237 Human Mob-5 (IL-24) receptors and uses thereof |
| 10/02/2007 | US7276227 Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |
| 10/02/2007 | CA2168583C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 09/27/2007 | WO2007109733A2 Diagnostic and prognostic markers and treatment strategies for multiple sclerosis |
| 09/27/2007 | WO2007109441A2 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 09/27/2007 | WO2007109144A1 Titinic ion channel, compositions and methods of use |
| 09/27/2007 | WO2007109135A2 Neuromedin u receptor agonists and uses thereof |
| 09/27/2007 | WO2007109035A2 Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine |
| 09/27/2007 | WO2007108882A2 Glycosylated g-csf |
| 09/27/2007 | WO2007108829A2 Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
| 09/27/2007 | WO2007108808A1 Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis |
| 09/27/2007 | WO2007108675A1 Methods of binding of cross-beta structures by chaperones |
| 09/27/2007 | WO2007108644A1 New gene and polypeptides of insulin-like growth factor-2 |
| 09/27/2007 | WO2007108643A1 New gene and polypeptides of platelet derived growth factor b |
| 09/27/2007 | WO2007108568A1 Hn epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope |
| 09/27/2007 | WO2007108557A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 09/27/2007 | WO2007108554A1 Peptide having anti-hypertensive activity |
| 09/27/2007 | WO2007108393A1 Method for in vitro proliferation of male germline stem cells |
| 09/27/2007 | WO2007107996A2 Novel nucleotide and amino acid sequences and methods of use thereof for diagnosis |
| 09/27/2007 | WO2007107807A1 Production of alpha-linolenic acid in sunflower |
| 09/27/2007 | WO2007107759A1 Peptide derived from colostrum |
| 09/27/2007 | WO2007107573A1 Use of polypeptides having antimicrobial activity |
| 09/27/2007 | WO2007107563A2 Muteins of tear lipocalin with affinity for the t-cell coreceptor cd4 |
| 09/27/2007 | WO2007107516A2 D-amino acid selection for soybean |
| 09/27/2007 | WO2007107488A2 Vaccine against trypanosoma cruzi infection |
| 09/27/2007 | WO2007107335A1 Complexes of nadp with the protein maba of mycobacterium tuberculosis or with mutants thereof, and their uses for designing and screening antibiotics |
| 09/27/2007 | WO2007107326A1 Stress resistant plants |
| 09/27/2007 | WO2007107323A2 Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy |
| 09/27/2007 | WO2007107302A2 Novel genes encoding insecticidal proteins |
| 09/27/2007 | WO2007107156A2 Chimeric viral envelopes |
| 09/27/2007 | WO2007107003A1 Markers for the diagnosis, monitoring and prognosis of osteoporosis and for assessing the risk for osteoporosis and for osteoporotic fractures |
| 09/27/2007 | WO2007107002A1 Markers for the diagnosis, monitoring and prognosis of osteoporosis and for assessing the risk for osteoporosis and for osteoporotic fractures |
| 09/27/2007 | WO2007106991A1 Identification of crmp4 as a convergent regulator of axon outgrowth inhibition |
| 09/27/2007 | WO2007106951A1 Antimicrobial protein |
| 09/27/2007 | WO2007088051A3 Modulation of mdl-1 activity for treatment of inflammatory disease |
| 09/27/2007 | WO2007080622A3 Luminescent stem cells and uses thereof |
| 09/27/2007 | WO2007075557A3 Methods and compositions for increasing the nitrogen storage capacity of a plant |
| 09/27/2007 | WO2007056195A3 Surfactant protein-d for prevention and treatment of lung infections and sepsis |
| 09/27/2007 | WO2007047653A3 Synthetic hla binding peptide analogues of mutant v617f jak2 enzyme and uses therefor |
| 09/27/2007 | WO2007027561A3 Systems and methods for fractionation of protein mixtures |
| 09/27/2007 | WO2007016210A3 Methylation markers for prognosis and treatment of cancers |
| 09/27/2007 | WO2006124859A3 Identification of a fusion/entry receptor for human herpesvirus-8 |
| 09/27/2007 | WO2005046583A3 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
| 09/27/2007 | US20070226843 Precise breeding - backbone integration markers |
| 09/27/2007 | US20070226841 Precise breeding - simultaneous silencing |
| 09/27/2007 | US20070226838 Precise breeding-marker-free transformation |
| 09/27/2007 | US20070226815 Protein with immunomodulatory activity, antiviral activity, and antitumor activity encoded by a IFN-alpha upregulated gene; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals, primers, probes, antibodies |
| 09/27/2007 | US20070225482 immobilization with control over the orientation of the attachment; efficient, not requiring the previous purification of the protein to be attached, and can be activated by UV-light; photolithography |
| 09/27/2007 | US20070225480 small ubiquitin-like modifier (SUMO); for diagnosis and treatment of Type 1 diabetes |
| 09/27/2007 | US20070225243 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor |
| 09/27/2007 | US20070225231 using polypeptides that can bind specifically to the CH2-CH3 cleft of an immunoglobulin molecule to inhibit Fc-mediated immune complex formation; rheumatoid arthritis |
| 09/27/2007 | US20070225226 C-reactive protein apheresis |
| 09/27/2007 | US20070225224 Modified Vitamin K-Dependent Polypeptides |
| 09/27/2007 | US20070225223 Modified Vitamin K-Dependent Polypeptides |
| 09/27/2007 | US20070225222 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 09/27/2007 | US20070225221 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 09/27/2007 | US20070225218 Extracellular Messengers |
| 09/27/2007 | US20070225215 Modulation of Cartilage Homeostasis By Active Domains of Cell Binding Extracellular Matrix Molecules |
| 09/27/2007 | US20070225214 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 09/27/2007 | US20070225210 Therapeutic vaccine compositions for the treatment of type 1 diabetes |
| 09/27/2007 | US20070225207 Group 1 Mite Polypeptide Variants |
| 09/27/2007 | US20070225205 Interferon-alpha polypeptides and conjugates |
| 09/27/2007 | US20070225204 Interferon-alpha polypeptides and conjugates |
| 09/27/2007 | US20070224665 Using coordinate directed mutation to generate of interest; directed protein evolution |
| 09/27/2007 | US20070224663 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods |
| 09/27/2007 | US20070224656 Modulation of Abeta levels by beta-secretase BACE2 |
| 09/27/2007 | US20070224649 Novel scavenger receptor |
| 09/27/2007 | US20070224647 Monitor protein for measuring processing of protein |
| 09/27/2007 | US20070224634 Methods for Detecting L-Ficolin Dependent Activation of the Lectin Pathway of Complement and Kits Therefor |
| 09/27/2007 | US20070224633 Muteins of Tear Lipocalin |
| 09/27/2007 | US20070224624 Nucleic acid encoding spinocerebellar ataxia-2 and products related thereto |
| 09/27/2007 | US20070224609 Genotoxic Testing |
| 09/27/2007 | US20070224608 Recombinant 12-KDA protein useful for the detection of respiratory allergies |
| 09/27/2007 | US20070224224 Protozoan Strains of Reduced Virulence and Use Thereof |
| 09/27/2007 | US20070224222 Neisserial Vaccines |
| 09/27/2007 | US20070224218 Viral antigens |
| 09/27/2007 | US20070224217 Virulence genes of M. marinum and M. tuberculosis |
| 09/27/2007 | US20070224212 for therapeutic treatment against HIV infection by inhibiting the virus-host cell membrane fusion process; inhibitors of HIV infectivity |
| 09/27/2007 | US20070224208 Ras mutation and compositions and methods related thereto |
| 09/27/2007 | US20070224201 Maytansinoid conjugated immunoglobulin for use in prevention, detection and treatment of cell proliferative disorders |
| 09/27/2007 | US20070224197 Three-dimensional structure of complement receptor type 2 and uses thereof |
| 09/27/2007 | US20070224195 Antitumor agents; enhanced by administration of cytoxic T lymphocyte (CTLA-4) blocker and/or cytosine-guanosine (CpG) oligodeoxynucleotide immunomodulators |
| 09/27/2007 | US20070224194 Methods for Inhibiting Angiogenesis and/or Lymphangiogenesis |
| 09/27/2007 | US20070224186 Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor |
| 09/27/2007 | US20070224185 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
| 09/27/2007 | US20070224178 Multimeric constructs |
| 09/27/2007 | US20070224127 Cardiovascular disorders such as myocardial infarction, post-myocardial infarction remodeling, and congestive heart failure |
| 09/27/2007 | US20070224125 Polypeptide of given sequence; transforming or transfecting cell with expression vector; inhibits tumor necrosis factor release; anti-inflammatory |